Two Sigma Advisers’s CapForce IBD 50 ETF FFTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-11,900
Closed -$330K 2364
2024
Q2
$330K Sell
11,900
-21,800
-65% -$594K ﹤0.01% 2031
2024
Q1
$931K Sell
33,700
-15,700
-32% -$410K ﹤0.01% 1614
2023
Q4
$1.2M Buy
49,400
+30,100
+156% +$685K ﹤0.01% 1550
2023
Q3
$432K Sell
19,300
-10,200
-35% -$246K ﹤0.01% 1843
2023
Q2
$755K Buy
29,500
+18,600
+171% +$441K ﹤0.01% 1651
2023
Q1
$258K Buy
+10,900
New +$250K ﹤0.01% 2193

Other funds holding FFTY

Two Sigma Advisers's FFTY Position: Q3 2024 in Review

Two Sigma Advisers sold out of CapForce IBD 50 ETF (FFTY) in Q3 2024, closing a stake of 11,900 shares — an estimated $330K sold.

Two Sigma Advisers first reported a position in FFTY in Q1 2023 and held it in 6 quarters. The position peaked at $1.2M in Q4 2023. 29 funds tracked by Wall St. Rank hold FFTY as of Q3 2024.

  • Two Sigma Advisers reported no remaining CapForce IBD 50 ETF position as of Q3 2024 after selling out during the quarter.
  • Two Sigma Advisers sold 11,900 CapForce IBD 50 ETF shares in Q3 2024, an estimated $330K.
  • Two Sigma Advisers first reported a position in CapForce IBD 50 ETF in Q1 2023 and held it in 6 quarters.
  • Two Sigma Advisers's CapForce IBD 50 ETF position peaked at $1.2M in Q4 2023.
  • 29 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q3 2024.

Based on Two Sigma Advisers's 13F filing for Q3 2024, filed 14 Nov 2024.